Opioid Overdose PreventionPROTECT-EDNCT07868393
Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department
A study testing PROTECT-ED Care Coordination in people with Opioid Overdose Prevention and HIV Prevention and Care, run by Johns Hopkins University at 1 site in United States.
Trial summary
The Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition from the Emergency Department (PROTECT-ED) study evaluates an emergency department-based implementation strategy designed to improve delivery of evidence-based overdose and HIV prevention services during community re-entry. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Opioid Overdose Prevention, HIV Prevention and Care, Harm Reduction
- What is being tested?
- PROTECT-ED Care Coordination
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Nov 2026to 1 Oct 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Are 18 years of age or older.
- Present to the Johns Hopkins Hospital Emergency Department.
- Have been released within the previous 180 days from a prison, jail, juvenile detention facility, immigration detention facility, halfway house, residential reentry center, or other correctional setting. Recent incarceration may be confirmed through participant self-report, electronic medical record documentation, the Victim Information and Notification Everyday (VINE) system, or other available documentation. Participant self-report alone is sufficient to establish eligibility.
- Meet criteria for opioid use disorder or hazardous opioid use and are considered appropriate for evaluation for medications for opioid use disorder (MOUD) or are at risk for HIV acquisition.
- Able to speak and understand communicate in English sufficiently to provide informed consent and complete study assessments.
- Provide informed consent.
- Have a reliable telephone number for study follow-up.
Who cannot join
- Inability to provide informed consent during the index emergency department encounter.
- Lack of a reliable telephone number for study follow-up.
- Prior enrollment in the PROTECT-ED study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Chris Hoffmann, MD, MSc, MPH contact
United States1 site
The Johns Hopkins Hospital Emergency Department
Baltimore, Maryland, 21287
About this study
Official title: Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department (PROTECT-ED)
The Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition from the Emergency Department (PROTECT-ED) study evaluates an emergency department-based implementation strategy designed to improve delivery of evidence-based overdose and HIV prevention services during community re-entry.
Read the detailed description
- Background Individuals returning to the community following incarceration experience one of the highest periods of preventable morbidity and mortality observed in clinical medicine. During the weeks and months following release from correctional facilities, rates of fatal opioid overdose increase by as much as 10- to 100-fold, while the risk of HIV acquisition is estimated to be 6- to 20-fold higher than that of the general population. These risks reflect the convergence of opioid use disorder, disrupted healthcare access, unstable housing, poverty, stigma, untreated mental illness, and fragmented transitions between correctional and community healthcare systems. Although effective biomedical interventions exist--including medications for opioid use disorder (MOUD) and HIV pre-exposure prophylaxis (PrEP)--many recently incarcerated individuals do not successfully engage in or remain connected to these services during community re-entry. Historically, efforts to improve continuity of care have focused on correctional health systems and community re-entry programs. These approaches have demonstrated important benefits but remain limited by incomplete implementation, inconsistent access across jurisdictions, and substantial loss to follow-up during the transition from incarceration to community living. Consequently, many individuals with ongoing opioid-related and HIV-related risks remain disconnected from preventive healthcare during the period of greatest vulnerability. The emergency department represents an underutilized opportunity to address this implementation gap. Between one-quarter and one-half of individuals released from incarceration seek care in an emergency department within the first year following release, and for many, the emergency department serves as the only point of contact with the healthcare system. Contemporary emergency departments have increasingly expanded beyond episodic acute care to incorporate evidence-based public health interventions, including overdose prevention, medications for opioid use disorder, HIV screening, and initiation of HIV pre-exposure prophylaxis. These developments position the emergency department as a critical venue for delivering integrated preventive services to individuals who may otherwise remain unreached by traditional healthcare systems. PROTECT-ED was developed to leverage this unique healthcare touchpoint by integrating peer-delivered prevention services, evidence-based biomedical prevention, harm reduction, and facilitated linkage to ongoing community care into a single emergency department encounter. Rather than evaluating the efficacy of MOUD or PrEP--which are already supported by extensive evidence--the study evaluates an implementation strategy designed to improve the reach, uptake, and continuity of these established interventions among recently incarcerated individuals. The intervention is informed by the Behavioral Model for Vulnerable Populations, which recognizes that healthcare utilization is shaped by predisposing characteristics, enabling resources, and perceived and evaluated need for care. By addressing barriers across each of these domains during an existing emergency department visit, PROTECT-ED seeks to improve engagement with preventive services during community re-entry.
- Study Objectives As a clinical trial planning study, the purpose of PROTECT-ED is to refine the intervention through participatory prototyping, evaluate the feasibility and preliminary clinical outcomes of implementation, and characterize implementation processes that will inform a future multicenter effectiveness-implementation trial. The knowledge generated through this study will provide the empirical and operational foundation necessary to scale emergency department-based overdose and HIV prevention strategies for individuals returning from incarceration nationally. The overarching objective of PROTECT-ED is to refine and evaluate an emergency department-based implementation strategy designed to improve uptake of evidence-based overdose and HIV prevention services among adults recently released from incarceration. Specifically, this study seeks to refine the intervention through stakeholder engagement, evaluate the feasibility and preliminary clinical outcomes of implementation, and characterize implementation processes to inform a future multi-center effectiveness-implementation trial.
- Aims The study consists of three integrated aims. Aim 1 focuses on refinement of the PROTECT-ED intervention through participatory prototyping involving individuals with lived experience, clinicians, correctional health partners, community-based organizations, and other stakeholders. Aim 2 evaluates the feasibility and preliminary clinical outcomes of the refined PROTECT-ED intervention through a prospective implementation trial enrolling 120 adults recently released from incarceration. Aim 3 evaluates implementation outcomes using mixed methods guided by the Practical, Robust, Implementation and Sustainability Model (PRISM). Quantitative and qualitative findings will characterize intervention reach, acceptability, contextual determinants, and implementation barriers and facilitators.
- Study Setting The study will be conducted within the Johns Hopkins Hospital Emergency Department, an urban, academic emergency department that evaluates approximately 60,000 adult patients annually. The emergency department has established clinical pathways for the identification and management of opioid use disorder, universal opt-out HIV screening, initiation of HIV pre-exposure prophylaxis, peer recovery services, and linkage to addiction medicine and infectious diseases care. The Johns Hopkins Hospital Emergency Department serves a large population of individuals affected by opioid use disorder, homelessness, structural vulnerability, and criminal-legal involvement.
- Conceptual Framework The PROTECT-ED intervention is informed by the Behavioral Model for Vulnerable Populations, which recognizes that healthcare utilization is influenced by predisposing characteristics, enabling resources, and perceived and evaluated need for care. The intervention seeks to improve engagement with overdose and HIV prevention services by addressing barriers across each of these domains during an emergency department encounter. Evaluation of implementation outcomes is guided by the Practical, Robust, Implementation and Sustainability Model (PRISM). PRISM provides a framework for understanding the interaction between the intervention, recipients, organizational context, external environment, and implementation infrastructure, and will inform refinement of the intervention and planning for future scale-up.
- Study Timeline The anticipated duration of the study is 36 months. Year 1: Regulatory approvals, participatory prototyping (Aim 1), intervention refinement, and study start-up.
Years 2-3: Participant enrollment, intervention delivery, follow-up assessments, and implementation evaluation (Aims 2 and 3).
Year 3: Data analysis, dissemination of findings, and development of a future multicenter effectiveness-implementation trial.
- Being tested
- PROTECT-ED Care Coordination
- Keywords
- Harm reduction, OUD, Justice-Involved Individuals, Healthcare Engagement
- Medical subject headings
- Harm Reduction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PROTECT-ED Care CoordinationBehavioural
Participants will receive the PROTECT-ED intervention during the index emergency department encounter. The intervention consists of systematic identification; peer-delivered prevention services; same-day offer and initiation of MOUD and PrEP, when clinically appropriate; harm reduction services; and facilitated linkage to ongoing community care. Clinical decisions regarding medication initiation remain the responsibility of the treating emergency department clinician. The ED clinician would prescribe medication as part of ED care delivery, this would include reviewing eligibility and dosing with the ED pharmacist.
| Study group | Role | What they receive |
|---|---|---|
| Aim 2 Study Participants | Other | Participants will receive the PROTECT-ED intervention during the index emergency department encounter. The intervention consists of systematic identification; peer-delivered prevention services; same-day offer and initiation of MOUD and PrEP, when clinically appropriate; harm reduction services; and facilitated linkage to ongoing community care. Clinical decisions regarding medication initiation remain the responsibility of the treating emergency department clinician. The ED clinician would prescribe medication as part of ED care delivery, this would include reviewing eligibility and dosing with the ED pharmacist. Receives: Behavioral: PROTECT-ED Care Coordination |
What is being measured
The primary outcome is the main question the study is designed to answer.
MOUD uptake
Proportion of participants initiating MOUD
Measured: 0-26 Weeks
MOUD and PrEP Uptake
Proportion of participants initiating MOUD and PrEP
Measured: 0-26 Weeks
PrEP Uptake
Proportion of participants initiating PrEP
Measured: 0-26 Weeks
Secondary outcomes (5)
MOUD persistence at 6 months
Proportion of participants on MOUD at 6 months among those who initiated
Measured: 26 Weeks
PrEP persistence at 6 months
Proportion of participants on PrEP at 6 months among those who initiated
Measured: 26 Weeks
Participants with Repeat emergency department utilization
Repeat emergency department utilization across Baltimore City
Measured: 0-26 Weeks
Opioid overdose events
Proportion of participants with 1+ opioid overdose events
Measured: 0-26 Weeks
Linkage and engagement in longitudinal care
Proportion of participants linked to care
Measured: 0-26 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Oct 2026
- Study start1 Nov 2026 (estimated)
- Primary completion1 Oct 2027 (estimated)
- Study completion1 Oct 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (14)Papers the sponsor has linked to this study.
- Other trials for Opioid Overdose PreventionStudies of the same condition, open and under way.
- More trials run by Johns Hopkins UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Johns Hopkins University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Responsible party
- Sponsor
- Investigators
- Bhakti Hansoti, MBChB, PhD, MPH, Principal investigator, Johns Hopkins University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07868393
- Sponsor's protocol ID
- IRB00574066
- Other IDs
- 1R34DA067263-01
- Acronym
- PROTECT-ED
- Status last verified
- Oct 2026
- First submitted
- 5 Oct 2026
- Last updated
- 9 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Vargas C, Zorbas C, Longworth GR, Ugalde A, Needham C, Sunil A, Venegas Hargous C, Bennett R, Forrester-Bowling T, Cardoso Richter AP, Allender S. Exploring co-design: a systematic review of concepts, processes, models, and frameworks used in public health research. J Public Health (Oxf). 2025 Dec 1;47(4):e616-e639. doi: 10.1093/pubmed/fdaf084.
PubMed 40796276Rousham E, Pareja RG, Creed-Kanashiro HM, Bartolini R, Pradeilles R, Ortega-Roman D, Holdsworth M, Griffiths P, Verdezoto N. Designing intervention prototypes to improve infant and young child nutrition in Peru: a participatory design study protocol. BMJ Open. 2023 Dec 9;13(12):e071280. doi: 10.1136/bmjopen-2022-071280.
PubMed 38070935Goldfarb DA. Surgical adrenal disorders. Semin Nephrol. 1994 Nov;14(6):570-9. No abstract available.
PubMed 7855463Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000 Feb;34(6):1273-302.
PubMed 10654830Eswaran V, Raven MC, Wang RC, Cawley C, Izenberg JM, Kanzaria HK. Understanding the association between frequent emergency department use and jail incarceration: A cross-sectional analysis. Acad Emerg Med. 2022 May;29(5):606-614. doi: 10.1111/acem.14437. Epub 2022 Feb 10.
PubMed 35064709Easter MM, Schramm-Sapyta NL, Tackett MA, Larsen IG, Tang B, Ralph MA, Huynh LN. Reliance on Community Emergency Departments by People Ever Detained in Jail: Retrospective Cross-Sectional Study. J Correct Health Care. 2023 Aug;29(4):282-292. doi: 10.1089/jchc.22.02.0011. Epub 2023 Jun 19.
PubMed 37335965Bazin H. Is antiinfectious defence thymus-dependent? Ann Inst Pasteur Immunol. 1988 Mar-Apr;139(2):187-9. doi: 10.1016/0769-2625(88)90040-2. No abstract available.
PubMed 3259426Humphreys J, Ahalt C, Stijacic-Cenzer I, Widera E, Williams B. Six-Month Emergency Department Use among Older Adults Following Jail Incarceration. J Urban Health. 2018 Aug;95(4):523-533. doi: 10.1007/s11524-017-0208-4.
PubMed 29204845Meyer JP, Qiu J, Chen NE, Larkin GL, Altice FL. Frequent emergency department use among released prisoners with human immunodeficiency virus: characterization including a novel multimorbidity index. Acad Emerg Med. 2013 Jan;20(1):79-88. doi: 10.1111/acem.12054.
PubMed 23570481Westergaard RP, Spaulding AC, Flanigan TP. HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis. 2013 Feb;26(1):10-6. doi: 10.1097/QCO.0b013e32835c1dd0.
PubMed 23221766Iroh PA, Mayo H, Nijhawan AE. The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health. 2015 Jul;105(7):e5-16. doi: 10.2105/AJPH.2015.302635. Epub 2015 May 14.
PubMed 25973818Spittal MJ, Forsyth S, Pirkis J, Alati R, Kinner SA. Suicide in adults released from prison in Queensland, Australia: a cohort study. J Epidemiol Community Health. 2014 Oct;68(10):993-8. doi: 10.1136/jech-2014-204295. Epub 2014 Jul 9.
PubMed 25009152Wang EA, Wang Y, Krumholz HM. A high risk of hospitalization following release from correctional facilities in Medicare beneficiaries: a retrospective matched cohort study, 2002 to 2010. JAMA Intern Med. 2013 Sep 23;173(17):1621-8. doi: 10.1001/jamainternmed.2013.9008.
PubMed 23877707Hartung DM, McCracken CM, Nguyen T, Kempany K, Waddell EN. Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data. J Subst Use Addict Treat. 2023 Apr;147:208971. doi: 10.1016/j.josat.2023.208971. Epub 2023 Feb 10.
PubMed 36821990
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department (PROTECT-ED)
- ClinicalTrials.gov ID
- NCT07868393
- Acronym / sponsor ID
- PROTECT-ED / IRB00574066
- Keywords
- Harm reduction, OUD, Justice-Involved Individuals, Healthcare Engagement
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Johns Hopkins UniversityUniversity, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Study start
- 1 Nov 2026 (estimated)
- Primary completion
- 1 Oct 2027 (estimated)
- Study completion
- 1 Oct 2028 (estimated)
- First posted
- 9 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition from the Emergency Department (PROTECT-ED) study evaluates an emergency department-based implementation strategy designed to improve delivery of evidence-based overdose and HIV prevention services during community re-entry.
Detailed description
- Background Individuals returning to the community following incarceration experience one of the highest periods of preventable morbidity and mortality observed in clinical medicine. During the weeks and months following release from correctional facilities, rates of fatal opioid overdose increase by as much as 10- to 100-fold, while the risk of HIV acquisition is estimated to be 6- to 20-fold higher than that of the general population. These risks reflect the convergence of opioid use disorder, disrupted healthcare access, unstable housing, poverty, stigma, untreated mental illness, and fragmented transitions between correctional and community healthcare systems. Although effective biomedical interventions exist--including medications for opioid use disorder (MOUD) and HIV pre-exposure prophylaxis (PrEP)--many recently incarcerated individuals do not successfully engage in or remain connected to these services during community re-entry. Historically, efforts to improve continuity of care have focused on correctional health systems and community re-entry programs. These approaches have demonstrated important benefits but remain limited by incomplete implementation, inconsistent access across jurisdictions, and substantial loss to follow-up during the transition from incarceration to community living. Consequently, many individuals with ongoing opioid-related and HIV-related risks remain disconnected from preventive healthcare during the period of greatest vulnerability. The emergency department represents an underutilized opportunity to address this implementation gap. Between one-quarter and one-half of individuals released from incarceration seek care in an emergency department within the first year following release, and for many, the emergency department serves as the only point of contact with the healthcare system. Contemporary emergency departments have increasingly expanded beyond episodic acute care to incorporate evidence-based public health interventions, including overdose prevention, medications for opioid use disorder, HIV screening, and initiation of HIV pre-exposure prophylaxis. These developments position the emergency department as a critical venue for delivering integrated preventive services to individuals who may otherwise remain unreached by traditional healthcare systems. PROTECT-ED was developed to leverage this unique healthcare touchpoint by integrating peer-delivered prevention services, evidence-based biomedical prevention, harm reduction, and facilitated linkage to ongoing community care into a single emergency department encounter. Rather than evaluating the efficacy of MOUD or PrEP--which are already supported by extensive evidence--the study evaluates an implementation strategy designed to improve the reach, uptake, and continuity of these established interventions among recently incarcerated individuals. The intervention is informed by the Behavioral Model for Vulnerable Populations, which recognizes that healthcare utilization is shaped by predisposing characteristics, enabling resources, and perceived and evaluated need for care. By addressing barriers across each of these domains during an existing emergency department visit, PROTECT-ED seeks to improve engagement with preventive services during community re-entry.
- Study Objectives As a clinical trial planning study, the purpose of PROTECT-ED is to refine the intervention through participatory prototyping, evaluate the feasibility and preliminary clinical outcomes of implementation, and characterize implementation processes that will inform a future multicenter effectiveness-implementation trial. The knowledge generated through this study will provide the empirical and operational foundation necessary to scale emergency department-based overdose and HIV prevention strategies for individuals returning from incarceration nationally. The overarching objective of PROTECT-ED is to refine and evaluate an emergency department-based implementation strategy designed to improve uptake of evidence-based overdose and HIV prevention services among adults recently released from incarceration. Specifically, this study seeks to refine the intervention through stakeholder engagement, evaluate the feasibility and preliminary clinical outcomes of implementation, and characterize implementation processes to inform a future multi-center effectiveness-implementation trial.
- Aims The study consists of three integrated aims. Aim 1 focuses on refinement of the PROTECT-ED intervention through participatory prototyping involving individuals with lived experience, clinicians, correctional health partners, community-based organizations, and other stakeholders. Aim 2 evaluates the feasibility and preliminary clinical outcomes of the refined PROTECT-ED intervention through a prospective implementation trial enrolling 120 adults recently released from incarceration. Aim 3 evaluates implementation outcomes using mixed methods guided by the Practical, Robust, Implementation and Sustainability Model (PRISM). Quantitative and qualitative findings will characterize intervention reach, acceptability, contextual determinants, and implementation barriers and facilitators.
- Study Setting The study will be conducted within the Johns Hopkins Hospital Emergency Department, an urban, academic emergency department that evaluates approximately 60,000 adult patients annually. The emergency department has established clinical pathways for the identification and management of opioid use disorder, universal opt-out HIV screening, initiation of HIV pre-exposure prophylaxis, peer recovery services, and linkage to addiction medicine and infectious diseases care. The Johns Hopkins Hospital Emergency Department serves a large population of individuals affected by opioid use disorder, homelessness, structural vulnerability, and criminal-legal involvement.
- Conceptual Framework The PROTECT-ED intervention is informed by the Behavioral Model for Vulnerable Populations, which recognizes that healthcare utilization is influenced by predisposing characteristics, enabling resources, and perceived and evaluated need for care. The intervention seeks to improve engagement with overdose and HIV prevention services by addressing barriers across each of these domains during an emergency department encounter. Evaluation of implementation outcomes is guided by the Practical, Robust, Implementation and Sustainability Model (PRISM). PRISM provides a framework for understanding the interaction between the intervention, recipients, organizational context, external environment, and implementation infrastructure, and will inform refinement of the intervention and planning for future scale-up.
- Study Timeline The anticipated duration of the study is 36 months. Year 1: Regulatory approvals, participatory prototyping (Aim 1), intervention refinement, and study start-up.
Years 2-3: Participant enrollment, intervention delivery, follow-up assessments, and implementation evaluation (Aims 2 and 3).
Year 3: Data analysis, dissemination of findings, and development of a future multicenter effectiveness-implementation trial.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Aim 2 Study Participants | Other | Behavioral: PROTECT-ED Care CoordinationParticipants will receive the PROTECT-ED intervention during the index emergency department encounter. The intervention consists of systematic identification; peer-delivered prevention services; same-day offer and initiation of MOUD and PrEP, when clinically appropriate; harm reduction services; and facilitated linkage to ongoing community care. Clinical decisions regarding medication initiation remain the responsibility of the treating emergency department clinician. The ED clinician would prescribe medication as part of ED care delivery, this would include reviewing eligibility and dosing with the ED pharmacist. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Are 18 years of age or older.
- Present to the Johns Hopkins Hospital Emergency Department.
- Have been released within the previous 180 days from a prison, jail, juvenile detention facility, immigration detention facility, halfway house, residential reentry center, or other correctional setting. Recent incarceration may be confirmed through participant self-report, electronic medical record documentation, the Victim Information and Notification Everyday (VINE) system, or other available documentation. Participant self-report alone is sufficient to establish eligibility.
- Meet criteria for opioid use disorder or hazardous opioid use and are considered appropriate for evaluation for medications for opioid use disorder (MOUD) or are at risk for HIV acquisition.
- Able to speak and understand communicate in English sufficiently to provide informed consent and complete study assessments.
Key exclusion criteria (3 listed)
- Inability to provide informed consent during the index emergency department encounter.
- Lack of a reliable telephone number for study follow-up.
- Prior enrollment in the PROTECT-ED study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PROTECT-ED Care CoordinationParticipants will receive the PROTECT-ED intervention during the index emergency department encounter. The intervention consists of systematic identification; peer-delivered prevention services; same-day offer and initiation of MOUD and PrEP, when clinically appropriate; harm reduction services; and facilitated linkage to ongoing community care. Clinical decisions regarding medication initiation remain the responsibility of the treating emergency department clinician. The ED clinician would prescribe medication as part of ED care delivery, this would include reviewing eligibility and dosing with the ED pharmacist. | Behavioural | Aim 2 Study Participants |
Primary outcome
MOUD uptake
Time frame: 0-26 Weeks
Proportion of participants initiating MOUD
MOUD and PrEP Uptake
Time frame: 0-26 Weeks
Proportion of participants initiating MOUD and PrEP
PrEP Uptake
Time frame: 0-26 Weeks
Proportion of participants initiating PrEP
5 secondary outcomes
MOUD persistence at 6 months
Time frame: 26 Weeks
PrEP persistence at 6 months
Time frame: 26 Weeks
Participants with Repeat emergency department utilization
Time frame: 0-26 Weeks
Opioid overdose events
Time frame: 0-26 Weeks
Linkage and engagement in longitudinal care
Time frame: 0-26 Weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Background: PubMed 40796276Vargas C, Zorbas C, Longworth GR, Ugalde A, Needham C, Sunil A, Venegas Hargous C, Bennett R, Forrester-Bowling T, Cardoso Richter AP, Allender S. Exploring co-design: a systematic review of concepts, processes, models, and frameworks used in public health research. J Public Health (Oxf). 2025 Dec 1;47(4):e616-e639. doi: 10.1093/pubmed/fdaf084.
- Background: PubMed 38070935Rousham E, Pareja RG, Creed-Kanashiro HM, Bartolini R, Pradeilles R, Ortega-Roman D, Holdsworth M, Griffiths P, Verdezoto N. Designing intervention prototypes to improve infant and young child nutrition in Peru: a participatory design study protocol. BMJ Open. 2023 Dec 9;13(12):e071280. doi: 10.1136/bmjopen-2022-071280.
- Background: PubMed 7855463Goldfarb DA. Surgical adrenal disorders. Semin Nephrol. 1994 Nov;14(6):570-9. No abstract available.
- Background: PubMed 10654830Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000 Feb;34(6):1273-302.
- Background: PubMed 35064709Eswaran V, Raven MC, Wang RC, Cawley C, Izenberg JM, Kanzaria HK. Understanding the association between frequent emergency department use and jail incarceration: A cross-sectional analysis. Acad Emerg Med. 2022 May;29(5):606-614. doi: 10.1111/acem.14437. Epub 2022 Feb 10.
- Background: PubMed 37335965Easter MM, Schramm-Sapyta NL, Tackett MA, Larsen IG, Tang B, Ralph MA, Huynh LN. Reliance on Community Emergency Departments by People Ever Detained in Jail: Retrospective Cross-Sectional Study. J Correct Health Care. 2023 Aug;29(4):282-292. doi: 10.1089/jchc.22.02.0011. Epub 2023 Jun 19.
- Background: PubMed 3259426Bazin H. Is antiinfectious defence thymus-dependent? Ann Inst Pasteur Immunol. 1988 Mar-Apr;139(2):187-9. doi: 10.1016/0769-2625(88)90040-2. No abstract available.
- Background: PubMed 29204845Humphreys J, Ahalt C, Stijacic-Cenzer I, Widera E, Williams B. Six-Month Emergency Department Use among Older Adults Following Jail Incarceration. J Urban Health. 2018 Aug;95(4):523-533. doi: 10.1007/s11524-017-0208-4.
- Background: PubMed 23570481Meyer JP, Qiu J, Chen NE, Larkin GL, Altice FL. Frequent emergency department use among released prisoners with human immunodeficiency virus: characterization including a novel multimorbidity index. Acad Emerg Med. 2013 Jan;20(1):79-88. doi: 10.1111/acem.12054.
- Background: PubMed 23221766Westergaard RP, Spaulding AC, Flanigan TP. HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis. 2013 Feb;26(1):10-6. doi: 10.1097/QCO.0b013e32835c1dd0.
- Background: PubMed 25973818Iroh PA, Mayo H, Nijhawan AE. The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health. 2015 Jul;105(7):e5-16. doi: 10.2105/AJPH.2015.302635. Epub 2015 May 14.
- Background: PubMed 25009152Spittal MJ, Forsyth S, Pirkis J, Alati R, Kinner SA. Suicide in adults released from prison in Queensland, Australia: a cohort study. J Epidemiol Community Health. 2014 Oct;68(10):993-8. doi: 10.1136/jech-2014-204295. Epub 2014 Jul 9.
Related trials for Opioid Overdose Prevention
Enrolling by invitation
PATH to Reducing Burnout Among Peers Who Deliver Overdose Prevention Services (R33 Phase Clinical Trial)
Burnout, Secondary Trauma
Recruiting
The ENHANCE Project Toolkit
Substance Related Disorder, Drug Overdose
Not yet recruiting
Remote Intervention to Prevent Overdose
Accidental Overdose of Opiate
Not yet recruitingPhase 1/2
Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
Opioid Use Disorder, Opioid Withdrawal
Not yet recruiting
Clinician Practice Companion to Address Youth Substance Use
Substance Use, Substance-Related Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Chris Hoffmann, MD, MSc, MPH contact
Bhakti Hansoti, MBChB, PhD, MPH principal investigator
Johns Hopkins University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing PROTECT-ED Care Coordination in people with Opioid Overdose Prevention and HIV Prevention and Care, run by Johns Hopkins University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bhakti Hansoti, MBChB, PhD, MPH (410-955-5000, bhansot1@jh.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
MOUD uptake (time frame: 0-26 Weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07868393, which also lists 14 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.